Haibing Xiao
Shenzhen Institute of Information Technology(CN)Yangtze University(CN)Anhui Medical University(CN)Qinghai Normal University(CN)Sinovac Biotech(CN)Yanshan University(CN)Foxconn (China)(CN)Changzhou Academy of Intelli-Ag Equipment (China)(CN)First Affiliated Hospital of Anhui Medical University(CN)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Ferroptosis and cancer prognosis, Epigenetics and DNA Methylation
Most-Cited Works
- → LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma(2015)219 cited
- → Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression(2014)198 cited
- → Smoking, Air Pollution, and the High Rates of Lung Cancer in Shenyang, China(1989)176 cited
- → Erratum To: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy(2014)128 cited
- → Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer(2016)124 cited
- → Folic acid-modified Exosome-PH20 enhances the efficiency of therapy via modulation of the tumor microenvironment and directly inhibits tumor cell metastasis(2020)119 cited